Business Description
Anavex Life Sciences Corp. is a drug development company focused on finding new treatments for brain and nervous system conditions, including Alzheimer's disease, Parkinson's disease, Rett syndrome, and certain cancers. Its most advanced compound, blarcamesine, is a pill designed to support healthy cell function and has been tested in multiple clinical trials across several of these conditions. The company is also advancing a second drug candidate that has shown promise in slowing the progression of Alzheimer's disease in laboratory studies. Founded in 2004, Anavex is headquartered in New York City.
